This structure also identifies a water molecule which is located in appropriate position to attack the re face of PEP during the course of the reaction, allowing the catalytic mechanism for this enzyme to be clearly defined.
INTRODUCTION
Tuberculosis (TB) remains a serious global health threat with over a million deaths per year. The recent emergence of multi-drug resistant strains of Mycobacterium tuberculosis, the pathogen that causes the lung disease, highlights the need for rapid development of new antibacterial drugs to combat TB (1-4).
3-Deoxy-D-arabino-heptulosonate 7-phosphate synthase (DAH7PS) is an important enzyme in Mycobacterium tuberculosis and other pathogens. It catalyzes the first committed step in the shikimate pathway, which is responsible for the biosynthesis of aromatic amino acids and other essential aromatic metabolites in microorganisms, plants, and apicomplexan parasites (5) (6) (7) . This pathway is absent in humans, and inhibitors of amino acid biosynthesis have been shown to be effective antimicrobial and herbicidal agents (8, 9) . Gene disruption studies have demonstrated that M. tuberculosis is not viable if the shikimate pathway is not operational (10) . These findings make DAH7PS an attractive target for drug development.
DAH7PS catalyzes the aldol-like condensation of phosphoenol pyruvate (PEP) and D-erythrose-4-phosphate (E4P) to yield 3-deoxy-D-arabinoheptulusonate 7-phosphate (Figure 1 (a) ). The reaction mechanism has been subject to extensive study, and many of the key details of the mechanism have been elucidated (11) (12) (13) (14) (15) (16) . The reaction occurs stereospecifically with respect to both substrates, with the si face of PEP attacking the re face of E4P. A divalent metal ion present in the active site is essential for activity. The reaction takes place with cleavage of the C-O bond of PEP rather than the O-P bond, requiring water to attack C2 of PEP at some stage during the reaction.
Figure 1
A mechanism consistent with the data published to date starts with nucleophilic attack of PEP at the E4P aldehyde moiety resulting in the formation of oxocarbenium species 1 (Figure 1 (b) ). This oxocarbenium ion 1 can be attacked by an active site water to form phosphohemiketal 2. It is noteworthy that water can potentially attack from either face of 1, giving rise to two possible diastereoisomers of tetrahedral intermediate 2, differing in their absolute configuration at C2. Although this stereogenic centre is transient, and the stereochemical information is lost by elimination of phosphate in the final step to generate the produc DAH7P (3), the geometry of the enzyme active site is likely to favor stereoselective attack of water to form one diastereoisomer of 2 preferentially. In this way DAH7P is formed in its acyclic form, and cyclizes into its cyclic pyranose form following release from the enzyme.
3-Deoxy-D-manno-octulosonate 8-phosphate synthase (KDO8PS), an enzyme involved in the synthesis of the lipopolysaccharide of cell wall of Gram-negative bacteria, is structurally and evolutionary related to DAH7PS. KDO8PS catalyzes an analogous reaction between PEP and the five-carbon sugar arabinose 5-phosphate (A5P) (17). Studies of the reaction mechanism of KDO8PS suggest that water is activated by the active site metal prior to attack at the reaction intermediate (18) . Computational and structural studies of KDO8PS indicate that after activation, water or hydroxide attacks from the si face of PEP resulting in overall syn addition of A5P and a hydroxyl group to the double bond of PEP (19) . Due to lack of comparable data for the reaction catalyzed by DAH7PS it is unclear whether these findings also apply to the reaction catalyzed by DAH7PS. Despite the similarities in their reaction chemistry, a number of key structural and mechanistic differences of DAH7PS and KDO8PS such as divalent metal ion requirement and substrate specificity have also been identified (20) .
M. tuberculosis DAH7PS (MtuDAH7PS) is the only member of the DAH7PS type II family that has been structurally characterized (21) (22) (23) . Type II DAH7PS enzymes show very little sequence homology with their type I DAH7PS counterparts, which are relatively well characterized and are found in organisms such as Escherichia coli (14, 15) and Saccharomyces cerevisiae (16, 24) . Both type I and type II DAH7PS enzymes share the common triosephophate isomerase (TIM barrel) fold, and mechanistic studies have suggested that the key details of the reaction chemistry are similar for enzymes of both DAH7PS types (25) . Despite the low sequence similarity the active site architecture of MtuDAH7PS shows remarkable correspondence to that of type I enzymes ( Figure  2 ). PEP is held in place by a tightly knit network of interactions. The PEP phosphate forms salt bridges to Lys306 (MtuDAH7PS numbering) and Arg337 and forms a hydrogen bond to the backbone N-H of Glu283, while the PEP carboxylate forms a salt bridge to Arg126. The metal ion is coordinated by His369, Glu411, Cys87 and Asp441 in a trigonal pyramidal fashion, leaving one coordination site potentially free for the carbonyl moiety of the E4P aldehyde moiety, thereby activating this functionality to nucleophilic attack. The proposed E4P binding site is constituted mostly by a 133 KPRS 136 -motif that is highly conserved in the type II subfamily, whereas members of the type I DAH7P synthase subfamily display a very similar, also highly conserved KPRT-motif at the equivalent position. The best indication of how E4P is bound to the enzyme can be found in the crystal structure of S. cerevisiae type I DAH7PS (SceDAH7PS) in complex with the E4P analogue, glycerol 3-phosphate (G3P) (16). Arginine and threonine from the KPRT motif interact with the G3P phosphate moiety, while the primary hydroxyl group of G3P forms a hydrogen bond to the backbone carbonyl of the proline residue of the KPRT motif, and the secondary hydroxyl interacts with the metal-coordinating aspartate.
Despite the many similarities in active site architecture and reaction chemistry between DAH7P synthases from different organisms and families, there are some significant distinctions of type II DAH7P synthases. For example, Trp280 forms part of the PEP-binding site in MtuDAH7PS, whereas in the E. coli and S. cerevisiae enzymes this residue is replaced by Ala. However, in the type I enzymes the space occupied by Trp280 is occupied by a Tyr residue from another part of the structure. Another significant distinction between MtuDAH7PS and all other DAH7P synthases characterized to date is its complex mechanism of allosteric regulation which we have recently investigated in detail (22) . Furthermore, the recent discovery that M. tuberculosis chorismate mutase is activated in complex with DAH7PS suggests a key role of DAH7PS in the regulatory network of aromatic metabolism of M. tuberculosis (26) .
Figure 2
In vitro studies with mechanism-based inhibitors have been previously reported for E. coli DAH7PS (27, 28 Expression, purification and crystallization of MtuDAH7PS. M. tuberculosis DAH7PS was overexpressed and purified as previously described (21) (22) (23) . A reservoir solution containing 400 µM of inhibitor was prepared by dissolving an appropriate amount of solid rac-4 in crystallization buffer (0.1 M Tris-HCl buffer at pH 8, 1.5 M ammonium sulfate, and 12% v/v glycerol). 500 µL of enzyme stock solution was concentrated to approximately 50 µL using centrifugation with a 10 kDa cutoff membrane, and the resulting solution was diluted to approximately 500 µL using the inhibitor solution. This process was repeated twice in order to buffer exchange the solution as completely as possible. 1 µL of the buffer exchanged enzyme solution (concentration 3-5 mg/mL) was mixed with 1 µL of crystallization buffer. Crystals were grown by sitting drop vapour diffusion over 300 µL of reservoir solution and appeared within 24 h at 25°C. Crystals were flash frozen in liquid nitrogen in a cryoprotectant solution consisting of crystallization buffer and 20% v/v glycerol.
Structure determination. X-ray diffraction data were collected at the MX2 beamline at the Australian Synchrotron ( Table 1 ). The dataset was integrated using iMosflm (30) . The space group and cell parameters were identical to those of previously reported structures of MtuDAH7PS allowing phases calculated from the original structure (PDB-code 2B7O) (21) to be used to solve the structure. The structure was refined using the CCP4 software package (30) by methods analogous to the ones described for the native structure (21) . Both enantiomers of inhibitor 4 were built using the Dundee PRODRG2 server (31) . The two enantiomers of 4 were initially positioned manually into the electron density observed in the active site using COOT and then refined at half occupancy. The model was optimized using repetitive cycles of model building with COOT and refinement with REFMAC5. Water molecules were added automatically in COOT and verified using |2F o -F c | and |F o -F c | maps and potential to hydrogen bond to at least one protein atom or other water molecule. A bias removed |F o -F c | omit map ( Figure  5 (a)) was generated by deleting the ligand and active site waters from the model and subjecting the model to simulated annealing and refinement in PHENIX. The |2F o -F c | map obtained by this procedure ( Figure 5 (a)) shows clear continuous electron density for ligand 4. The structure was validated using SFCHECK, with 97.5% of residues in the most favored region of the Ramachandran plot ( Table 1 ). The final model included two protein chains each containing all 462 natural residues and two residues from His tag cleavage, 554 water molecules, two manganese ions, one sulfate ion, one chloride ion and R-and S-4.
Inhibition assays. Enzyme activity was monitored by following the loss of absorbance at 232 nm (ε=2800 L mol -1 cm -1 ) due to the consumption of PEP (32) . Assays were carried out in 50 mM BTP buffer at pH 7.5 containing 1 mM tris(2-carboxyethyl)phosphine (TCEP) at 30°C. The buffer solution was prepared using ultrapure water which was stirred over Chelex resin (Bio-Rad) and filtered before use. Manganese(II) sulfate stock solution (10 mM) was made up in ultrapure water pretreated with Chelex resin. PEP and E4P substrate solutions were made up to approximately 10 mM by dissolving the PEP monopotassium salt and E4P monosodium salt (Aldrich) in buffer solution. Accurate substrate concentrations were determined by enzymatic reaction: The absorbance change of solutions containing one substrate in excess were determined before and after conversion of the limiting substrate by added DAH7PS had occurred and the extinction coefficient of PEP was used to calculate the concentration of the limiting substrate. The absorbance change was corrected by the absorbance change caused when DAH7PS was added to a control solution which did not contain E4P. For inhibition studies, assay solutions containing manganese (II), varying concentrations of PEP and inhibitors and buffer were equilibrated at 30°C. 2 µl (1.3 mg/mL) M. tuberculosis DAH7PS was added and the mixture equilibrated for 2 min before the reaction was initiated by addition of E4P (11 µL). Final assay conditions were 10 µM Mn 2+ , 5.2 nM DAH7PS, 100 µM E4P, 57.6-115.2 µM PEP, 0-940 nM inhibitor with an appropriate amount of buffer to make up a final volume of 1 mL.
Lanzetta phosphate assay. Lanzetta reagent (33) was prepared fresh as required from the following components: 3 parts 0.045% w/v malachite green in water, 1 part 4.2% w/v ammonium molybdate in 4 M HCl, 0.1 parts 1.5% v/v Triton X-100 in water. The components were mixed in the dark and stirred for 1 h before the solution was filtered through a 0.45 µM syringe filter. For the qualitative detection of phosphate-containing fractions after anion exchange chromatography, a 20 µL sample of each fraction was mixed with 250 µL of Lanzetta reagent and the color change judged by optical inspection. For the quantitative determination of inhibitor concentration, 300 µL of the inhibitor solutions were incubated with 10 µL calf alkaline phosphatase solution (5 units/mL in 4 mM MgCl 2 ) for at least 2 h. To 100 µL of the digested sample was added 700 µL Lanzetta reagent and the absorbance at 630 nm determined after 20 minutes. A calibration curve for the determination of phos-phate concentration was obtained from analogous analysis of solutions of appropriate concentrations (6-150 µM) of KH 2 PO 4 which had been dried in high vacuum for at least 3 h before use. As a control, a glucose-6-phosphate solution of known concentration was also digested with calf alkaline phosphatase and analyzed. (36) . The induced fit docking procedure lead to an intermediate adapted protein receptor in which several residues in the active site adopted conformations different to the ones observed in the native crystal structure (PDB-code 2B7O). This intermediate adapted structure of MtuDAH7PS was then used as a rigid receptor for docking studies of compounds (R)-and (S)-4 which were conducted using Glide (37) .
Synthesis. All reactions were carried out under an inert atmosphere of nitrogen in flame-dried glassware unless otherwise stated. Organic solvents were dried before use by standard methods (38) . Dess-Martin Periodinane (39, 40) was prepared according to literature procedures. mChloroperbenzoic acid was recrystallized from dichloromethane before use, all other reagents were purchased from Sigma-Aldrich and used without further purification.
Preparative procedures and characterization of previously unreported compounds can be found in the Supplemental Data. A representative procedure for the final step of the synthesis and characterization of inhibitor 4 is outlined in detail below.
Heptanoic acid 2,7-bisphosphate 4. Protected bisphosphate 11 (177 mg, 0.24 mmol) was dissolved in ethyl acetate (15 mL) and palladium on charcoal (10% Pd/C, 57 mg, 0.053 mmol Pd) was added. The reaction flask was purged with hydrogen gas with three freeze-pump-thaw cycles. The reaction mixture was stirred for 16 h after which TLC indicated complete consumption of starting material 11. The suspension was filtered through a celite pad, the celite washed with ethyl acetate and methanol and the solvent evaporated under reduced pressure. The resulting residue was dissolved in 1 M aqueous potassium hydroxide solution (7 mL) and stirred vigorously for 2.5 h. The reaction mixture was passed down a column consisting of freshly regenerated DOWEX 50W x4-200 (H+) resin (approximately 5x1 cm) and the column eluted with 50 mL water. The eluate was neutralized with 1 M potassium hydroxide solution and lyophilized. The crude product was purified by anion exchange chromatography on SOURCE-Q resin eluting with a gradient of water/aqueous ammonium bicarbonate solution. Fractions containing the desired product were identified using the qualitative Lanzetta phosphate assay (see below), pooled and lyophilized to give 42.5 mg of a white powder consisting of the product and residual ammonium bicarbonate. Lanzetta phosphate assay (see above) established the purity of the white powder yielded was 80% by weight, the corrected yield for this step is thus 34%. 
RESULTS

Modeling of the reaction intermediate into
Figure 3
The best pose from the modeling study (Figure 3 (a)) was selected based on two criteria. The first is that the PEP part of the tetrahedral intermediate retains the same interactions as observed in the original crystal structure (PDB-code 2B7O). The second is that the positioning of the E4P phosphate group should be as close as possible to the phosphate group of G3P in the crystal structure of SceDAH7PS (PDB-code 1OF8), which is considered to provide the best prediction for the E4P phosphate position. In the best pose (Figure 3  (a) ), the PEP part of the molecule interacts with Arg126, Lys306, Arg337, Arg284 and Glu283. Arg284 bridges the phosphate groups of PEP and E4P through salt bridges and hydrogen bonds. The E4P phosphate group interacts with Arg284, Arg135, and Ser136, which suggests that part of the KPRS motif (Arg135 and Ser136) plays a key role in positioning of the E4P phosphate, as expected from the G3P-bound SceDAH7PS structure. The E4P aldehyde group, now converted to a hydroxyl group in the linear intermediate, is at a distance of 2.2 Å from the metal ion. This indicates that the aldehyde of E4P may be held in place by coordination to the metal ion before reaction occurs. The hydroxyl group that corresponds to the incoming water molecule forms hydrogen bonds with Trp280, Glu248, and Lys133. Two of these residues, Glu248 and Lys133, are conserved across the entire DAH7PS family, whereas Trp280 is only conserved in the type II enzymes. and held together by a non-functionalized hydrocarbon linker. Given its low degree of functionalization, bisphosphate 4 may be used as a lead structure for specific introduction of functionality in order to enhance enzyme-ligand affinity. In light of the results for molecular modeling of the tetrahedral intermediate 2 which suggest a preference for the S configuration at C2, we devised two syntheses leading to target compound 4 in order to assess possible enantiodiscrimination: One racemic synthesis which had already been proven useful in our laboratory, as well as a chiral pool synthesis which allowed control of the absolute configuration at C2.
Synthesis of racemic 4.
The synthetic strategy towards rac-4 relies on the establishment of the key α-hydroxyester moiety by a Darzen's-type chain elongation of an aldehyde, a methodology that has been used for the synthesis of related compounds ( Figure 4 ) (29, 41) . The final deprotection was achieved by hydrogenolysis of the benzyl groups followed hydrolysis of the isopropyl ester. The final product, rac-4 was purified by anion exchange chromatography eluting with an ammonium bicarbonate gradient.
Figure 4
Crystal structure. The racemic inhibitor 4 was cocrystallized with DAH7PS from M. tuberculosis. Whereas generally both purification of the enzyme and crystal growth are difficult in the absence of PEP in the buffer solution, x-ray diffraction quality crystals were obtained by buffer exchange of the purified enzyme solution with a solution containing inhibitor 4 ( (22) showed that 5029 atoms could be matched with an rms positional difference of 0.22 Å.
Table 1
Clear continuous electron density for inhibitor 4 was found in both active sites. The |F o -F c | omit map generated by removing the inhibitor and active site waters from the model and subjecting the resulting model to simulated annealing and refinement shows clear continuous density for inhibitor 4, and for a water molecule in the active site ( Figure 5 (a)). Based on the electron density maps obtained, it could not be concluded whether there is preferential binding of one of the enantiomers from the racemic mixture. In order to represent this ambiguity, our final model includes both (R)-4 and (S)-4 at half occupancy.
Figure 5
Inhibitor 4 binds as predicted with its 2-phosphoryl and carboxylate moieties in the PEP binding site, and in an extended conformation so that the phosphate moiety on C7 is located near the proposed E4P phosphate binding site ( Figure 5 (b) ). Active site residues interacting with the PEPmimicking portion of ligand 4 show little movement, consistent with this portion of the inhibitor being a good mimic of PEP. As expected, the conformations of the metal-binding residues were unaffected by binding of compound 4. The 2-phosphate moiety of inhibitor 4 forms salt bridges with Arg284, Arg337 and Lys306 and a hydrogen bond to the backbone N-H of Glu283. The carboxyl group forms salt bridges with Lys133 and Arg126 and coordinates to the manganese ion present in the active site. The 7-phosphate moiety extends into the tentative E4P phosphate binding site, forming salt bridges with Lys380 and Arg135 and hydrogen bonds with the Ser136 hydroxyl-group and backbone N-H. Conformational changes relative to the PEP-liganded structure were observed for the KPRS motif associated with inhibitor binding ( Figure 5 (c) ). Arg135 and Ser136 interact with the 7-phosphate moiety of inhibitor 4, moving closer into the active site pocket. The side chain of Lys133 shows the biggest conformational change of all active site residues, establishing a salt bridge to the carboxylate group of ligand 4. This big movement may also be partly due to increased electrostatic repulsion with the guanidinium group of Arg135, which has moved closer into the active site. Interestingly, the side chain movement of Lys133 correlates well with the movement that the induced fit molecular modeling results predict for this residue in order to accommodate the proposed reaction intermediate ( Figure 5 (d) ).
The Encouraged by these results, and in order to assess whether one enantiomer of 4 is preferentially bound by the enzyme, we synthesized compounds (R)-4 and (S)-4 for inhibition assays.
Synthesis of (R)-4 and (S)-4.
Since the previously described synthesis of rac-4 offers little potential with respect to stereoselective introduction of the α-hydroxyester moiety, another synthetic route was developed in which the chirality is derived from a cheap and readily available chiral pool starting material ( Figure 6 ). The chiral epoxyester 14 of appropriate configuration was prepared from D-or L-serine respectively following a previously reported method (42) . Ethyl glycidate 14 could be ring opened regioselectively α-hydroxyester 15.
Hydrogenolysis of ester 15 liberated the 7-hydroxyl group to generate dihydroxyester 16, which could then be converted to (R)-4 or (S)-4 using the same procedures as described above for the racemic synthesis.
Figure 6
Inhibition studies. (R)-4 and (S)-4 were tested for inhibition of MtuDAH7PS. Although inhibitor 4 was designed as a bisubstrate inhibitor, it is known that DAH7PS operates by a sequential ordered reaction mechanism in which PEP has to bind to the enzyme first (25) . This means that although competition with PEP is most important in order to assess the inhibitory potency, the fixed concentration of the second substrate can influence the inhibition. The kinetic assays were carried out with PEP concentrations ranging from 57 to 115 µM at a fixed E4P concentration of 100 µM, which corresponds to four times the value determined for the Michaelis constant for E4P (K m (E4P)). The concentrations of (R)-4 and (S)-4 were varied from 0-940 nM. Even at these high levels of E4P, (R)-4 and (S)-4 gave inhibitory constants of 360 ± 50 and 620 ± 110 nM respectively (see Supplemental Data Figure S1 and S2). (R)-4 and (S)-4 represent the first potent inhibitors reported for MtuDAH7PS and the first inhibitors with substantially greater affinity than the substrate PEP (K m (PEP)=29 µM for MtuDAH7PS) for any DAH7P synthase. 
Modeling of (R)-4 and (S)-4 into
DISCUSSION
The study presented here demonstrates the successful combination of synthetic, structural and computational methods in order to inform the design of novel lead structures of inhibitors for MtuDAH7PS. Although both the substrate and the product of the enzymatic transformation, PEP and DAH7P, possess planar geometry at C2, mechanistic considerations suggest that the enzyme active site is also set up to accommodate preferentially a tetrahedral reaction intermediate. The high inhibitory potencies of (R)-and (S)-4 confirm that intermediate analogues with tetrahedral C2 are a promising scaffold for highaffinity inhibitors of DAH7PS.
The fact that the experimentally determined structure and the induced-fit model are in good agreement demonstrates firstly, that inhibitor 4 is a good intermediate mimic, and secondly, verifies that our modeling approach is effective for predictions of enzyme-ligand interactions for MtuDAH7PS. The structural information from the enzyme-inhibitor complex can be used to inform future inhibitor design: based on the binding mode of inhibitor 4 in the active site, modifications to the lead structure allow the introduction of specific new interactions with the enzyme. For example, additional hydroxyl groups at C4 and C6 of inhibitor 4 with the appropriate absolute configuration are expected to form hydrogen bonds to Asp441, interactions which were observed in the modeling of the intermediate (Figure 3 ). Introduction of a C4-hydroxyl or other metal coordinating group such as an amine or thiol group could also lead to additional enzyme-inhibitor interactions through metal coordination.
Inhibitor 4 is a highly charged molecule, featuring two phosphate groups and a carboxylate moiety. This characteristic of this molecule is expected to significantly limit membrane permeability. Phosphates are abundant in naturally occurring molecules, making them highly interesting moieties in the development of drugs. Strategies to generate phosphate prodrugs containing suitable masking groups that facilitate membrane permeability and allow the release of the active drug inside the cell have been developed, and examples of these prodrugs are in clinical trials (43) (44) (45) .
Although both enantiomers of inhibitor 4 displayed a high affinity to the enzyme active site, the small difference in affinity of the two enantiomers provides valuable insight into the enzyme mechanism and its inhibition. The observation that (S)-4 proved to be a slightly less potent inhibitor may be due to the fact that the C2-hydrogen of (S)-4 points in the direction of a water molecule also present in the active site, with inter-atom distances that suggest a steric clash between these moieties. ( Figure S4 , Supplemental Data). For the related enzyme KDO8PS, data from computational and crystallographic studies have lead to the preposition that the substrate water attacks PEP from the si side during the course of the reaction (18, 19, 46) . It however so far remains unclear whether this mechanistic proposal can be transferred to MtuDAH7PS or even DAH7P synthases in general. In the crystal structure reported in this study, a water molecule was located in close proximity to C2 of the inhibitor on what would be the re side of PEP. The resemblance of this arrangement of inhibitor and water to the location of the 2-hydroxyl group of the modeled tetrahedral reaction intermediate, combined with the configurational preference observed for the docking of the intermediate, suggest that in MtuDAH7PS, water attack proceeds from the re side of PEP. This is further supported by studies of type I DAH7P synthases from S. cerevisiae (16), E. coli (14) , and Thermotoga maritima (47) , which located a water molecule that was suggested to attack PEP during the course of the enzymatic reaction in a very similar environment. The glutamic acid residue has been proposed as a general base catalyst to facilitate nucleophilic attack of water. The highly conserved nature of the arrangement of water in the PEP binding site suggests a common catalytic mechanism for all DAH7P synthases which involves water attacking the re face of PEP during the course of the reaction. A similar mechanism has been previously suggested in studies of S. cerevisiae and T. maritima type I DAH7PS (16, 47). The fact that a glutamate residue is found at the equivalent position for M. tuberculosis type II DAH7PS, and the crystallographic localization of a suitable substrate water molecule in the MtuDAH7PS-4-complex in this study as well as our modeling results further support this mechanistic proposition. In the next step, the now neutral Lys133 can abstract the proton from Glu248, by either direct deprotonation or relayed via an active site water molecule. This step regenerates both the Lys133 ammonium and the Glu248 carboxylate group necessary for the next catalytic cycle. Lys306, which is positioned within hydrogen bonding distance of the PEP phosphate, could aid the elimination of phosphate from tetrahedral intermediate 2 by protonating the phosphate thus making it a better leaving group. Elimination of hydrogen phosphate yields DAH7PS protonated on the 2-keto moiety; this proton can then be removed by Lys306. After dissociation of the product DAH7P, all active site residues have returned to the protonation state that is required for the next catalytic turnover. This mechanism is the simplest that is in accordance with the data published to date, and it accounts for all protonation and deprotonation steps required on active site residues and intermediates. The only major side chain movement of an active site residue is required from the proton-shuttling Lys133, a residue which is not well defined or possesses high B-factor values in some crystal structures of DAH7P synthases, indicating mobility of its side chain (11, 21) . Further support for the important role of both Lys133 and Lys306 comes from results in our laboratory that show both residues are essential for catalytic activity. 
CONCLUSION
By combining molecular modeling-guided and mechanism-based design we have synthesized the first potent inhibitor of MtuDAH7PS. The crystal structure of the enzyme-inhibitor complex shows that the structural features of the inhibitor designed to mimic features of the natural substrates and proposed reaction intermediate indeed leads to the predicted specific enzyme inhibitor interactions. Inhibitor 4 represents a promising lead structure for anti-mycobacterial drugs and offers ample opportunity for further modification in order to establish structure-activity relationships. The crystallographic location of an active site water molecule has clarified the enzyme catalytic mechanism. Figure 6: Synthesis of enantiopure inhibitor 4: yields are given for the synthesis of (R)-4, analogous procedures using L-serine as the starting material were used for the synthesis of (S) 
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